Mathieu Chevrier News Today

A $2.8 million share buyback has helped restore $1.2 billion of value to Pro Medicus. Despite its sky-high multiple, bulls think it has further to run.

By Stuart Condie SYDNEY--Cochlear shares jumped in early trade Thursday after the hearing-implant manufacturer said sales had been stronger than anticipated...

Dutch health technology company Philips will not sell new devices to treat sleep apnea in the U.S. in the coming years as it works to comply with a

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0247 GMT – Fisher &…

Maxine Jaquet also said rents had hit record highs as she defended the company’s performance against criticism from Tanarra Capital, a major investor.

Citi analyst Mathieu Chevrier maintained a Hold rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) to...

Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) received a Hold rating and price target from Jarden analys...

In a report released today, Mathieu Chevrier from Citi maintained a Hold rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF &#...

Head of research and development Bill Mezzanotte said the cost of bringing a treatment like its Hemgenix to market exceeded $US1 billion ($1.49 billion)

Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2023 Results Conference Call November 28, 2022 04:00 PM ET Company Participants Marcus Driller - Vice President,...